Current Edition

Pediatric melanoma and the pharmaceutical
European Medicines Agency

Paediatric Melanoma and the Pharmaceutical Industry

The age of paediatric melanoma used to be a theoretical discussion, but has become a real-life challenge due to arbitrary age limits decreed by regulatory …

Continue Reading →